Moleculin Biotech, Inc. (MBRX): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-15, first reflected in a filing dated 2024-03-22; 1-for-25, first reflected in a filing dated 2026-03-18. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

3.20M
As of 2025-12-31
7.10M
As of 2026-06-30
28.58M2015-12-31: 6.66M2016-12-31: 12.16M2017-12-31: 21.47M2018-12-31: 28.53M2019-12-31: 7.62M2020-12-31: 11.54M2021-12-31: 28.58M2022-12-31: 1.91M2023-12-31: 2.23M2024-12-31: 135.2K2025-12-31: 3.20M3.20M
2015-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedShares OutstandingChange YoYSource filing
2025-12-313.20Mn/m2026-03-18, Balance as of period end
2024-12-31135.2Kn/c2026-03-18, Balance as of period end
2023-12-312.23M+16.7%2025-03-21, Balance as of period end
2022-12-311.91Mn/c2024-03-22, Balance as of period end
2021-12-3128.58M+147.7%2022-03-24, Balance as of period end
2020-12-3111.54Mn/c2022-03-24, Balance as of period end
2019-12-317.62M-73.3%2021-03-24, Balance as of period end
2018-12-3128.53M+32.9%2020-03-19, Balance as of period end
2017-12-3121.47M+76.5%2019-02-21, Balance as of period end
2016-12-3112.16M+82.6%2018-03-28, Balance as of period end
2015-12-316.66Mn/a2017-04-03, Balance as of period end